StockDuty ← Dashboard Oct 30, 2026 06:14 AM ET
SignalFDA/Bio

Stoke outlines Q3 2027 EMPEROR readout and plans NDA submission in second half 2027

Stoke targets Q3 2027 EMPEROR readout and NDA submission in second half 2027.

Stoke targets Q3 2027 EMPEROR readout and NDA submission in second half 2027.
Stoke targets Q3 2027 EMPEROR readout and NDA submission in second half 2027. — impact context not separately stored; see What changed.
Sources